Table 20 Antitumor activity of the synthesized derivatives (60a-j) Sharma et al. [40]
From: Synthesis and therapeutic potential of imidazole containing compounds
Compounds | Substituent R | Substituent R’ | DLA cells CTC50 μg/mL | EAC cells CTC50 μg/mL |
|---|---|---|---|---|
60a |
|
| 190.26 | 60.50 |
60b |
|
| 114.00 | 240.00 |
60c |
|
| 98.56 | 31.25 |
60d |
|
| 309.67 | 200.22 |
60e |
|
|  > 500 | 489.34 |
60f |
|
| 207.60 | 115.31 |
60 |
|
| 238.50 | 31.25 |
60Â h |
|
|  > 500 |  > 500 |
60i |
|
| 405.68 | 305.91 |
60j |
|
| 150.26 | 94.63 |
